These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 2497333

  • 21. Treatment of malaria with sulfadoxine/pyrimethamine: note of caution.
    Gozal D, Hengy C.
    Lancet; 1990 Jul 14; 336(8707):111-2. PubMed ID: 1975290
    [No Abstract] [Full Text] [Related]

  • 22. Indications for the use of Fansidar in malaria.
    Schwartz IK, Campbell CC.
    N Engl J Med; 1982 Jul 15; 307(3):194. PubMed ID: 7088068
    [No Abstract] [Full Text] [Related]

  • 23. Fansidar for malaria prophylaxis.
    Kissane D.
    Aust Fam Physician; 1985 Aug 15; 14(8):738. PubMed ID: 3901990
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A, Salako LA, Laoye AJ, Modupe Makinde J, Aina Adio R.
    Afr J Med Med Sci; 1988 Dec 15; 17(4):195-200. PubMed ID: 2854365
    [Abstract] [Full Text] [Related]

  • 25. Malaria chemoprophylaxis--which drug?
    Biddulph J.
    P N G Med J; 1983 Jun 15; 26(2):127-30. PubMed ID: 6388184
    [No Abstract] [Full Text] [Related]

  • 26. Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
    Herzog C, Kibbler CC, Ellis CJ, Mtawali CV.
    Br Med J (Clin Res Ed); 1983 Oct 01; 287(6397):947-8. PubMed ID: 6412900
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of falciparum malaria with sulfalene-pyrimethamine versus sulfadoxine-pyrimethamine.
    Chongsuphajaisiddhi T, Youngchaiyudha S, Rungpitarangsri V, Trishnananda M, Ruksakul T, Charnond L, Boonamrung S.
    Southeast Asian J Trop Med Public Health; 1980 Dec 01; 11(4):524-7. PubMed ID: 7013094
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
    Kupferschmidt HG, Schröder K, Beltzner B.
    Angew Parasitol; 1988 Nov 01; 29(4):211-3. PubMed ID: 3072886
    [Abstract] [Full Text] [Related]

  • 34. Falciparum malaria despite pyrimethamine/suifadoxine in five tourists to East Africa.
    Eichenlaub D, Rogler G, Hoffmann HG, Weise HJ.
    Lancet; 1982 Nov 06; 2(8306):1041-2. PubMed ID: 6127518
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pyrimethamine-sulfadoxine still effective against Plasmodium falciparum in Jayapura, Irian Jaya: RI-type resistance in 2 of 18 patients.
    Hoffman SL, Campbell J, Rustama D, Dimpudus AJ, Surumpaet B, Rusch J, Marwoto H.
    Trans R Soc Trop Med Hyg; 1987 Nov 06; 81(2):276-7. PubMed ID: 3303484
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya.
    Terlouw DJ, Aidoo MA, Udhayakumar V, Kolczak MS, Oloo AJ, Kager PA, Lal AA, Nahlen BL, Kuile FO.
    J Infect Dis; 2002 Dec 01; 186(11):1661-8. PubMed ID: 12447744
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.